Research Involving:
- Investigational New Drugs and Biologics
- Investigational Devices
- Significant Versus Non-Significant Devices
- Mobile Medical Applications
- ChatGPT/ Large Language Models (LLM)/ Artificial Intelligence (AI)
| Data Sharing |
Data Security Risk Assessment and Data Transfer Agreement A Data Security Risk Assessment by UCSF IT Security & Policy AND Data Transfer Agreement by the Office of Sponsored Research (OSR -- Industry Contracts Division) must be completed if your study involves: the collection, transmission, or storage of information when that data will be shared with or be accessible to any non-UCSF entity (e.g., pharmaceutical companies, UCSF Affiliated Institutions) or individual. This includes the use of third-party or vendor-hosted applications. UCSF or department-hosted applications may also need to be assessed in accordance with UCOP Policy IS-3 Electronic Information Security, particularly if they are new applications or have never been reviewed by UCSF IT Security & Policy.
These requirements apply for both identifiable and de-identified data for funded and unfunded research. Questions about these policies must be directed to UCSF IT and OSR, not to the IRB.
|
Resources
FDA
- Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies
- Is Your Clinical Decision Support Software a Device? The Clinical Decision Support Software guidance describes the regulatory approach to Clinical Decision Support (CDS) software functions. The decision tree offers a general and illustrative summary of this guidance.
- UCSF